Agile Therapeutics Inc Kiemelkedően
Mi az Agile Therapeutics Inc Kiemelkedően?
A Kiemelkedően az Agile Therapeutics Inc - 6.904M
Mi a Kiemelkedően meghatározása?
A fennálló részvények egy olyan vállalat vagy pénzügyi eszköz részvényei, amelyeket a befektetők engedélyeztek, bocsátottak ki és vásároltak meg.
Shares outstanding includes all stock held by investors including both common shares held by the public and restricted shares owned by the company's internal managements. Shares outstanding have rights and represent an ownership in the corporation by the person who holds the shares. They are distinguished from treasury shares, which are shares held by the corporation itself and have no exercisable rights. Shares outstanding plus treasury shares together amount to the number of issued shares.
Shares outstanding can be calculated as either basic or fully diluted. The basic count is the current number of shares. Dividend distributions and voting in the general meeting of shareholders are calculated according to this number. The fully diluted shares outstanding count, on the other hand, includes diluting securities, such as warrants, capital notes or convertibles. If the company has any diluting securities, this indicates the potential future increased number of shares outstanding. A company's market capitalization is calculated by multiplying the price of one of its shares by the total number outstanding shares a company has issued.
Kiemelkedően a Health Care szektor a NASDAQ-on cégekben a Agile Therapeutics Inc -hoz képest
Mit csinál Agile Therapeutics Inc?
agile therapeutics is a forward-thinking women's healthcare company dedicated to fulfilling the unmet health needs of today's women. our product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method. our lead product candidate, twirla®, (ethinyl estradiol and levonorgestrel transdermal system), also known as ag200-15, is a once-weekly prescription contraceptive patch that recently completed phase 3 trials. twirla is based on our proprietary transdermal patch technology, called skinfusion®, which is designed to provide advantages over currently available patches and is intended to optimize patch adhesion and patient wearability. for more information, please visit the company website at www.agiletherapeutics.com. connect with us on twitter at @agilether.
kiemelkedően -hoz hasonló cégek Agile Therapeutics Inc
- Infotel SA nak Kiemelkedően 6.888M van
- Firsthand Technology Value Fund Inc nak Kiemelkedően 6.893M van
- Adocia SA nak Kiemelkedően 6.895M van
- Jagan Lamps Ltd nak Kiemelkedően 6.895M van
- European Equity Fund Inc nak Kiemelkedően 6.902M van
- FP Newspapers nak Kiemelkedően 6.903M van
- Agile Therapeutics Inc nak Kiemelkedően 6.904M van
- Touax SCA nak Kiemelkedően 6.924M van
- Sunrise Realty Trust nak Kiemelkedően 6.925M van
- United Labels AG nak Kiemelkedően 6.930M van
- Midatech Pharma Plc nak Kiemelkedően 6.934M van
- Annovis Bio nak Kiemelkedően 6.947M van
- Gravity Co Ltd nak Kiemelkedően 6.949M van